The global vaccine alliance Gavi says it will buy 500,000 doses of vaccine against mpox to fight outbreaks of the disease in African countries.

The global vaccine group Gavi will buy 500,000 doses of Bavarian Nordic's mpox vaccine, its first purchase of the shot to help battle an outbreak in parts of Africa, the group said on Wednesday.In 2024,

Gavi, the Vaccine Alliance, is purchasing 500,000 mpox vaccines from Bavarian Nordic A/S for African countries hardest-hit by the lethal outbreak.

Mpox ( formerly known as monkeypox) is a viral infection that can be prevented with just a single dose of an existing vaccine, a new study finds. This discovery could help slow the tide of the global mpox outbreak, which was declared a public health emergency of international concern by the World Health Organization back in July 2022.

Gavi, the global vaccine group, announced it will purchase 500,000 doses of Bavarian Nordic’s mpox vaccine. This marks Gavi’s first acquisition of the vaccine to aid in combating an outbreak in parts of Africa.

The global vaccine group Gavi has ordered 500,000 mpox vaccine doses from the German-Danish company Bavarian Nordic. The UN Children's Fund is to deliver these to affected countries in Africa later this year,